News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Paolo Tarantino: Interesting data with TROP2 quantitative continuous scoring to predict Dato-DXd activity in lung cancer
Paolo Tarantino/X
Sep 14, 2024, 06:35

Paolo Tarantino: Interesting data with TROP2 quantitative continuous scoring to predict Dato-DXd activity in lung cancer

Paolo Tarantino posted the following on X:

“Interesting data with TROP2 quantitative continuous scoring (QCS) to predict the activity of Dato-DXd in lung cancer.”

Paolo Tarantino: Interesting data with TROP2 quantitative continuous scoring to predict Dato-DXd activity in lung cancer

Source: Paolo Tarantino/X

cancer Dato-DXd Lung cancer OncoDaily Oncology Paolo Tarantino QCS quantitative continuous scoring TROP2
Special Coverage
Blog
Apr 3, 2025, 18:05
Addressing Oncology Workforce Shortages through Local Partnerships and Early Career Recruitment
Blog
Apr 3, 2025, 17:54
Triparna Sen: Sen Lab Receives Third NIH/NCI R01 to Advance KRAS Co-mutant NSCLC Research
Blog
Apr 3, 2025, 17:53
PEGylated lipid screening, composition optimization, and structure-activity relationship determination for lipid nanoparticle-mediated mRNA delivery
Blog
Apr 3, 2025, 17:16
IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challenge
Blog
Apr 3, 2025, 17:06
Should NTCP Models Lead Clinical Decisions in Radiation Oncology? - ESTRO
Blog
Apr 3, 2025, 17:01
Tian Zhang invites to join The Advances in Cancer Immunotherapy webinar sponsored by SITC
Blog
Apr 3, 2025, 16:56
Travel Tips for Exploring Ghent’s Culture and History After SIOG 2025
Insight
Apr 3, 2025, 16:37
OncoBillionaires of 2025: The Titans Behind the Cancer Revolution
Blog
Apr 3, 2025, 16:09
Low-dose CT Scans Identify 80% of Early Lung Cancers in High-Risk Groups - Lung Cancer Europe
Blog
Apr 3, 2025, 16:04
Zainab Shinkafi-Bagudu: How creativity fuels advocacy
Blog
Apr 3, 2025, 15:12
The Advances in Cancer Immunotherapy - SITC
Science
Apr 3, 2025, 15:00
Jeff Ryckman: Fascinating results for neoadjuvant Aumolertinib in EGFR-Mutant NSCLC